Sort
48,018 grants matching “immunotherapy”
Improving T-cell therapies for neuroblastoma
$447,592Gianpietro Dotti · Baylor College Of Medicine · R01 · FY2011 · CA
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
$447,565Sebastian Joyce · Vanderbilt University Medical Center · R01 · FY2022 · DE
Project 2: Combined CAR-T cell therapy
$447,559Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
EXPRESSION OF TUBERCULOSIS IN THE LUNG
$447,557Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2002 · HL
Establishment, maintenance, and consequences of asymmetric cell division in T cells
$447,500Douglas R Green · St. Jude Children'S Research Hospital · R01 · FY2017 · AI
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
$447,478Scott S Zamvil · University Of California, San Francisco · R01 · FY2020 · AI
Activation of Human Natural Killer Cell Function
$447,474Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Molecular mechanisms of antibody-mediated immunotherapies
$447,450Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2023 · CA
EAMG: MIR structure and specific immunosuppressive therapy
$447,425Jon Martin Lindstrom · University Of Pennsylvania · R01 · FY2009 · NS
Interplay between tumor and microenvironment in bone metastasis
$447,407Paul B Fisher · Virginia Commonwealth University · R01 · FY2024 · CA
Targeting Neoantigens in Glioblastoma
$447,405Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2024 · NS
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$447,387Kai Yang · Indiana University Indianapolis · R01 · FY2021 · AI
Bioluminescence and Fluorescence Optical Animal Imager
$447,288Guillermo Marques · University Of Minnesota · S10 · FY2022 · OD
INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES
$447,239John C Byrd · Ohio State University · P01 · FY2007 · CA
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
$447,190David R Grosshans · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Immunobiology of Myeloid and Lymphoid Cells
$447,183William R Green · Dartmouth College · T32 · FY2008 · AI
Developmental Funds
$447,165Cheryl L Willman · Mayo Clinic Rochester · P30 · FY2022 · CA
Expanding the tumor antigen landscape and maintaining APCs in a T cell-activating state to restore tumor immunity
$447,162Eduardo Davila · University Of Colorado Denver · R01 · FY2023 · CA
Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes
$447,090Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HL
Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes
$447,090Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2017 · HL
Developmental Funds
$447,041Rafael Fonseca · Mayo Clinic Rochester · P30 · FY2021 · CA
Developmental Funds
$447,041Cheryl L Willman · Mayo Clinic Rochester · P30 · FY2023 · CA
Development of Antigen-specific B Cell Memory
$447,013Michael G. McHeyzer-Williams · Scripps Research Institute, The · R01 · FY2015 · AI
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$446,886E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2019 · NS
Function of IL35+ B cells in pancreatic cancer
$446,826Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2021 · CA